Safety of Telaprevir Treatment in Asian-American Adults with Genotype 1 Chronic Hepatitis C Virus Infection

被引：0
|
作者：
Pan, Calvin [1 ]
Zeng, Zheng [2 ]
Ouyang, Elsa [3 ]
机构：
[1] NYU Sch Med, NYU Langone Med Ctr, Div Gastroenterol & Hepatol, Flushing, NY USA
[2] Peking Univ, Hosp 1, Beijing 100871, Peoples R China
[3] St Johns Univ, Jamaica, NY 11439 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2013年 / 108卷
关键词：
D O I：
10.14309/00000434-201310001-00479
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
479
引用
收藏
页码：S142 / S143
页数：2
相关论文
共 50 条
  • [31] Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C virus infection in adults
    Nehra, V
    Rizza, S. A.
    Temesgen, Z.
    DRUGS OF TODAY, 2018, 54 (07) : 407 - 421
  • [32] Efficacy and safety of Chlorella supplementation in adults with chronic hepatitis C virus infection
    Jose Azocar
    Arley Diaz
    World Journal of Gastroenterology, 2013, (07) : 1085 - 1090
  • [33] Efficacy and safety of Chlorella supplementation in adults with chronic hepatitis C virus infection
    Azocar, Jose
    Diaz, Arley
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (07) : 1085 - 1090
  • [34] Comparative effectiveness and safety study of triple therapy with simeprevir or telaprevir for non-cirrhotic patients with chronic hepatitis C virus genotype 1b infection
    Ogawa, Eiichi
    Furusyo, Norihiro
    Kajiwara, Eiji
    Nomura, Hideyuki
    Kawano, Akira
    Takahashi, Kazuhiro
    Dohmen, Kazufumi
    Satoh, Takeaki
    Azuma, Koichi
    Nakamuta, Makoto
    Koyanagi, Toshimasa
    Kotoh, Kazuhiro
    Shimoda, Shinji
    Hayashi, Jun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (12) : 1759 - 1767
  • [35] Telaprevir A Review of its Use in the Management of Genotype 1 Chronic Hepatitis C
    Perry, Caroline M.
    DRUGS, 2012, 72 (05) : 619 - 641
  • [36] Development of hypocalcemia with telaprevir-based triple treatment in a case of genotype 1 chronic hepatitis C
    Senates, Ebubekir
    Colak, Yasar
    Yesil, Atakan
    Tuncer, Ilyas
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2015, 26 (03): : 283 - 283
  • [37] Comparative effectiveness and safety of boceprever and telaprevir for chronic genotype 1 hepatitis C in a community setting: interim analysis
    Loucks, Aimee R.
    Chan, Jim
    Hui, Rita L.
    Spence, Michele M.
    Szpakowski, Jean-Luc
    HEPATOLOGY, 2013, 58 : 1143A - 1144A
  • [38] Boceprevir for previously treated chronic hepatitis C virus genotype 1 infection
    Bathgate, A.
    JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2011, 41 (02): : 122 - 123
  • [39] Daclatasvir plus simeprevir with or without ribavirin for the treatment of chronic hepatitis C virus genotype 1 infection
    Zeuzem, Stefan
    Hezode, Christophe
    Bronowicki, Jean-Pierre
    Loustaud-Ratti, Veronique
    Gea, Francisco
    Buti, Maria
    Olveira, Antonio
    Banyai, Tivadar
    Al-Assi, M. Tarek
    Petersen, Joerg
    Thabut, Dominique
    Gadano, Adrian
    Pruitt, Ronald
    Makara, Mihaly
    Bourliere, Marc
    Pol, Stanislas
    Beumont-Mauviel, Maria
    Ouwerkerk-Mahadevan, Sivi
    Picchio, Gaston
    Bifano, Marc
    McPhee, Fiona
    Boparai, Navdeep
    Cheung, Kin
    Hughes, Eric A.
    Noviello, Stephanie
    JOURNAL OF HEPATOLOGY, 2016, 64 (02) : 292 - 300
  • [40] ECONOMIC EVALUATION OF BOCEPREVIR FOR THE TREATMENT OF PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C VIRUS INFECTION IN HUNGARY
    Odhiambo, R.
    Chhatwal, J.
    Ferrante, S. A.
    El Khoury, A.
    Elbasha, E.
    VALUE IN HEALTH, 2012, 15 (07) : A390 - A390
12345